CNS – Child Neurology Society Annual Meeting

Oct 14 – 17
Montreal, Canada

Fremanezumab, a CGRP pathway-targeting monoclonal antibody for migraine prevention in children and adolescents: findings by weight-based dose in the SPACE open-label extension study

Authors:
Christina Spzerka, Jennifer McVige, Andrew Hershey,, Marcy Yonker Janace Gifford, Thomas Li, Juline Bryson